General Manager at Sanofi UK and Ireland, Rippon Ubhi, and Jim Shannon MP discuss the burden of chronic obstructive pulmonary ...

As the UK endures another harsh winter, plummeting temperatures and a surge in respiratory infections are placing strain on ...

Poland: A recent simulation study published in Scientific Reports revealed that individuals with asthma and chronic ...

Regeneron Pharmaceuticals, Inc. faces Eylea revenue decline but shows growth potential with Dupixent & Libtayo. Click for ...

Most online pulmonary rehabilitation videos are understandable but lack key disease-specific information for conditions other than COPD.

For current and former smokers, statins may reduce the amount of chest muscle loss, while aspirin may contribute to increased ...

We recently published a list of 10 Best Performing Growth Stocks in 2025 In this article, we are going to take a look at ...

Despite early success, Verona's lack of specific 2025 guidance and competition from Dupixent and other drugs raise concerns.

For current and former smokers, statins may reduce the amount of chest muscle loss, while aspirin may contribute to increased chest muscle loss, according to a new study.

Early this year, Kamada announced that it expects continued double-digit growth – all while maintaining profitability – for ...

Among older adults in Spain, hospitalization rates from respiratory syncytial virus (RSV) infection increases progressively ...

Tricuspid regurgitation (TR) is common in patients with atrial functional mitral regurgitation (AFMR) but its impact is not ...